STARD8 Antikörper (AA 201-250)
Kurzübersicht für STARD8 Antikörper (AA 201-250) (ABIN6746633)
Target
Alle STARD8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 201-250
-
Spezifität
- Human STARD8
-
Homologie
- Percent identity by BLAST analysis:
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa201-250 of human STARD8 (Q92502, NP_001135975). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey (100%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
-
Approved: WB (1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- STARD8 (StAR-Related Lipid Transfer (START) Domain Containing 8 (STARD8))
-
Andere Bezeichnung
- STARD8
-
Hintergrund
-
Name/Gene ID: STARD8
Synonyms: STARD8, ARHGAP38, DLC-3, KIAA0189, START domain containing 8, START-GAP3, DLC3, STARTGAP3 -
Gen-ID
- 9754
-
NCBI Accession
- NP_001135975
-
UniProt
- Q92502
Target
-